Global Biologics Contract Manufacturing Service Market Growth (Status and Outlook) 2023-2030
- Category: Healthcare
- Published Date: Feb 2023
- Publisher: LP Information
- Pages: 101
The global market for Biologics Contract Manufacturing Service is estimated to increase from US$ million in 2022 to reach US$ million by 2030, exhibiting a CAGR of % during 2022-2030. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Biologics Contract Manufacturing Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2023 and 2030.
The United States Biologics Contract Manufacturing Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2023 and 2030.
The Europe Biologics Contract Manufacturing Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2023 and 2030.
The China Biologics Contract Manufacturing Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2023 and 2030.
Global key Biologics Contract Manufacturing Service players cover Lonza Group, Samsung Biologics, Thermo Fisher Scientific, Cambrex Corporation and Siegfried Holding AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2022.
Report Coverage
This latest report provides a deep insight into the global Biologics Contract Manufacturing Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Biologics Contract Manufacturing Service market, with both quantitative and qualitative data, to help readers understand how the Biologics Contract Manufacturing Service market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2022, while the market estimates and forecasts are given from 2022 to 2030. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Biologics Contract Manufacturing Service market and forecasts the market size by Type (Monoclonal Antibodies, Recombinant Proteins and Vaccines), by Application (Large Pharmaceutical Companies and Small And Medium Pharmaceutical Companies.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Molecular Therapy
Others
Segmentation by application
Large Pharmaceutical Companies
Small And Medium Pharmaceutical Companies
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Lonza Group
Samsung Biologics
Thermo Fisher Scientific
Cambrex Corporation
Siegfried Holding AG
Fujifilm Holding Corporation
AbbVie, Inc.
Boehringer Ingelheim
Recipharm Pharmaceuticals
WuXi Biologics
Catalent, Inc.
Chapter Introduction
Chapter 1: Scope of Biologics Contract Manufacturing Service, Research Methodology, etc.
Chapter 2: Executive Summary, global Biologics Contract Manufacturing Service market size and CAGR, Biologics Contract Manufacturing Service market size by region, by type, by application, historical data from 2019-2022, and forecast to 2030.
Chapter 3: Biologics Contract Manufacturing Service revenue, global market share, and industry ranking by company, 2019-2023
Chapter 4: Global Biologics Contract Manufacturing Service revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Biologics Contract Manufacturing Service market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Lonza Group, Samsung Biologics, Thermo Fisher Scientific, Cambrex Corporation, Siegfried Holding AG, Fujifilm Holding Corporation, AbbVie, Inc., Boehringer Ingelheim and Recipharm Pharmaceuticals, etc.
Chapter 14: Research Findings and Conclusion
The APAC Biologics Contract Manufacturing Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2023 and 2030.
The United States Biologics Contract Manufacturing Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2023 and 2030.
The Europe Biologics Contract Manufacturing Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2023 and 2030.
The China Biologics Contract Manufacturing Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2023 and 2030.
Global key Biologics Contract Manufacturing Service players cover Lonza Group, Samsung Biologics, Thermo Fisher Scientific, Cambrex Corporation and Siegfried Holding AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2022.
Report Coverage
This latest report provides a deep insight into the global Biologics Contract Manufacturing Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Biologics Contract Manufacturing Service market, with both quantitative and qualitative data, to help readers understand how the Biologics Contract Manufacturing Service market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2022, while the market estimates and forecasts are given from 2022 to 2030. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Biologics Contract Manufacturing Service market and forecasts the market size by Type (Monoclonal Antibodies, Recombinant Proteins and Vaccines), by Application (Large Pharmaceutical Companies and Small And Medium Pharmaceutical Companies.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Molecular Therapy
Others
Segmentation by application
Large Pharmaceutical Companies
Small And Medium Pharmaceutical Companies
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Lonza Group
Samsung Biologics
Thermo Fisher Scientific
Cambrex Corporation
Siegfried Holding AG
Fujifilm Holding Corporation
AbbVie, Inc.
Boehringer Ingelheim
Recipharm Pharmaceuticals
WuXi Biologics
Catalent, Inc.
Chapter Introduction
Chapter 1: Scope of Biologics Contract Manufacturing Service, Research Methodology, etc.
Chapter 2: Executive Summary, global Biologics Contract Manufacturing Service market size and CAGR, Biologics Contract Manufacturing Service market size by region, by type, by application, historical data from 2019-2022, and forecast to 2030.
Chapter 3: Biologics Contract Manufacturing Service revenue, global market share, and industry ranking by company, 2019-2023
Chapter 4: Global Biologics Contract Manufacturing Service revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Biologics Contract Manufacturing Service market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Lonza Group, Samsung Biologics, Thermo Fisher Scientific, Cambrex Corporation, Siegfried Holding AG, Fujifilm Holding Corporation, AbbVie, Inc., Boehringer Ingelheim and Recipharm Pharmaceuticals, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biologics Contract Manufacturing Service Market Size 2019-2030
2.1.2 Biologics Contract Manufacturing Service Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biologics Contract Manufacturing Service Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Recombinant Proteins
2.2.3 Vaccines
2.2.4 Molecular Therapy
2.2.5 Others
2.3 Biologics Contract Manufacturing Service Market Size by Type
2.3.1 Biologics Contract Manufacturing Service Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biologics Contract Manufacturing Service Market Size Market Share by Type (2019-2022)
2.4 Biologics Contract Manufacturing Service Segment by Application
2.4.1 Large Pharmaceutical Companies
2.4.2 Small And Medium Pharmaceutical Companies
2.5 Biologics Contract Manufacturing Service Market Size by Application
2.5.1 Biologics Contract Manufacturing Service Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biologics Contract Manufacturing Service Market Size Market Share by Application (2019-2022)
3 Biologics Contract Manufacturing Service Market Size by Player
3.1 Biologics Contract Manufacturing Service Market Size Market Share by Players
3.1.1 Global Biologics Contract Manufacturing Service Revenue by Players (2020-2022)
3.1.2 Global Biologics Contract Manufacturing Service Revenue Market Share by Players (2020-2022)
3.2 Global Biologics Contract Manufacturing Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biologics Contract Manufacturing Service by Regions
4.1 Biologics Contract Manufacturing Service Market Size by Regions (2019-2022)
4.2 Americas Biologics Contract Manufacturing Service Market Size Growth (2019-2022)
4.3 APAC Biologics Contract Manufacturing Service Market Size Growth (2019-2022)
4.4 Europe Biologics Contract Manufacturing Service Market Size Growth (2019-2022)
4.5 Middle East & Africa Biologics Contract Manufacturing Service Market Size Growth (2019-2022)
5 Americas
5.1 Americas Biologics Contract Manufacturing Service Market Size by Country (2019-2022)
5.2 Americas Biologics Contract Manufacturing Service Market Size by Type (2019-2022)
5.3 Americas Biologics Contract Manufacturing Service Market Size by Application (2019-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics Contract Manufacturing Service Market Size by Region (2019-2022)
6.2 APAC Biologics Contract Manufacturing Service Market Size by Type (2019-2022)
6.3 APAC Biologics Contract Manufacturing Service Market Size by Application (2019-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biologics Contract Manufacturing Service by Country (2019-2022)
7.2 Europe Biologics Contract Manufacturing Service Market Size by Type (2019-2022)
7.3 Europe Biologics Contract Manufacturing Service Market Size by Application (2019-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biologics Contract Manufacturing Service by Region (2019-2022)
8.2 Middle East & Africa Biologics Contract Manufacturing Service Market Size by Type (2019-2022)
8.3 Middle East & Africa Biologics Contract Manufacturing Service Market Size by Application (2019-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biologics Contract Manufacturing Service Market Forecast
10.1 Global Biologics Contract Manufacturing Service Forecast by Regions (2023-2030)
10.1.1 Global Biologics Contract Manufacturing Service Forecast by Regions (2023-2030)
10.1.2 Americas Biologics Contract Manufacturing Service Forecast
10.1.3 APAC Biologics Contract Manufacturing Service Forecast
10.1.4 Europe Biologics Contract Manufacturing Service Forecast
10.1.5 Middle East & Africa Biologics Contract Manufacturing Service Forecast
10.2 Americas Biologics Contract Manufacturing Service Forecast by Country (2023-2030)
10.2.1 United States Biologics Contract Manufacturing Service Market Forecast
10.2.2 Canada Biologics Contract Manufacturing Service Market Forecast
10.2.3 Mexico Biologics Contract Manufacturing Service Market Forecast
10.2.4 Brazil Biologics Contract Manufacturing Service Market Forecast
10.3 APAC Biologics Contract Manufacturing Service Forecast by Region (2023-2030)
10.3.1 China Biologics Contract Manufacturing Service Market Forecast
10.3.2 Japan Biologics Contract Manufacturing Service Market Forecast
10.3.3 Korea Biologics Contract Manufacturing Service Market Forecast
10.3.4 Southeast Asia Biologics Contract Manufacturing Service Market Forecast
10.3.5 India Biologics Contract Manufacturing Service Market Forecast
10.3.6 Australia Biologics Contract Manufacturing Service Market Forecast
10.4 Europe Biologics Contract Manufacturing Service Forecast by Country (2023-2030)
10.4.1 Germany Biologics Contract Manufacturing Service Market Forecast
10.4.2 France Biologics Contract Manufacturing Service Market Forecast
10.4.3 UK Biologics Contract Manufacturing Service Market Forecast
10.4.4 Italy Biologics Contract Manufacturing Service Market Forecast
10.4.5 Russia Biologics Contract Manufacturing Service Market Forecast
10.5 Middle East & Africa Biologics Contract Manufacturing Service Forecast by Region (2023-2030)
10.5.1 Egypt Biologics Contract Manufacturing Service Market Forecast
10.5.2 South Africa Biologics Contract Manufacturing Service Market Forecast
10.5.3 Israel Biologics Contract Manufacturing Service Market Forecast
10.5.4 Turkey Biologics Contract Manufacturing Service Market Forecast
10.5.5 GCC Countries Biologics Contract Manufacturing Service Market Forecast
10.6 Global Biologics Contract Manufacturing Service Forecast by Type (2023-2030)
10.7 Global Biologics Contract Manufacturing Service Forecast by Application (2023-2030)
11 Key Players Analysis
11.1 Lonza Group
11.1.1 Lonza Group Company Information
11.1.2 Lonza Group Biologics Contract Manufacturing Service Product Offered
11.1.3 Lonza Group Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Lonza Group Main Business Overview
11.1.5 Lonza Group Latest Developments
11.2 Samsung Biologics
11.2.1 Samsung Biologics Company Information
11.2.2 Samsung Biologics Biologics Contract Manufacturing Service Product Offered
11.2.3 Samsung Biologics Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Samsung Biologics Main Business Overview
11.2.5 Samsung Biologics Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Biologics Contract Manufacturing Service Product Offered
11.3.3 Thermo Fisher Scientific Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Cambrex Corporation
11.4.1 Cambrex Corporation Company Information
11.4.2 Cambrex Corporation Biologics Contract Manufacturing Service Product Offered
11.4.3 Cambrex Corporation Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Cambrex Corporation Main Business Overview
11.4.5 Cambrex Corporation Latest Developments
11.5 Siegfried Holding AG
11.5.1 Siegfried Holding AG Company Information
11.5.2 Siegfried Holding AG Biologics Contract Manufacturing Service Product Offered
11.5.3 Siegfried Holding AG Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Siegfried Holding AG Main Business Overview
11.5.5 Siegfried Holding AG Latest Developments
11.6 Fujifilm Holding Corporation
11.6.1 Fujifilm Holding Corporation Company Information
11.6.2 Fujifilm Holding Corporation Biologics Contract Manufacturing Service Product Offered
11.6.3 Fujifilm Holding Corporation Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Fujifilm Holding Corporation Main Business Overview
11.6.5 Fujifilm Holding Corporation Latest Developments
11.7 AbbVie, Inc.
11.7.1 AbbVie, Inc. Company Information
11.7.2 AbbVie, Inc. Biologics Contract Manufacturing Service Product Offered
11.7.3 AbbVie, Inc. Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 AbbVie, Inc. Main Business Overview
11.7.5 AbbVie, Inc. Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Biologics Contract Manufacturing Service Product Offered
11.8.3 Boehringer Ingelheim Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Recipharm Pharmaceuticals
11.9.1 Recipharm Pharmaceuticals Company Information
11.9.2 Recipharm Pharmaceuticals Biologics Contract Manufacturing Service Product Offered
11.9.3 Recipharm Pharmaceuticals Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Recipharm Pharmaceuticals Main Business Overview
11.9.5 Recipharm Pharmaceuticals Latest Developments
11.10 WuXi Biologics
11.10.1 WuXi Biologics Company Information
11.10.2 WuXi Biologics Biologics Contract Manufacturing Service Product Offered
11.10.3 WuXi Biologics Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 WuXi Biologics Main Business Overview
11.10.5 WuXi Biologics Latest Developments
11.11 Catalent, Inc.
11.11.1 Catalent, Inc. Company Information
11.11.2 Catalent, Inc. Biologics Contract Manufacturing Service Product Offered
11.11.3 Catalent, Inc. Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Catalent, Inc. Main Business Overview
11.11.5 Catalent, Inc. Latest Developments
12 Research Findings and Conclusion
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biologics Contract Manufacturing Service Market Size 2019-2030
2.1.2 Biologics Contract Manufacturing Service Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biologics Contract Manufacturing Service Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Recombinant Proteins
2.2.3 Vaccines
2.2.4 Molecular Therapy
2.2.5 Others
2.3 Biologics Contract Manufacturing Service Market Size by Type
2.3.1 Biologics Contract Manufacturing Service Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biologics Contract Manufacturing Service Market Size Market Share by Type (2019-2022)
2.4 Biologics Contract Manufacturing Service Segment by Application
2.4.1 Large Pharmaceutical Companies
2.4.2 Small And Medium Pharmaceutical Companies
2.5 Biologics Contract Manufacturing Service Market Size by Application
2.5.1 Biologics Contract Manufacturing Service Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biologics Contract Manufacturing Service Market Size Market Share by Application (2019-2022)
3 Biologics Contract Manufacturing Service Market Size by Player
3.1 Biologics Contract Manufacturing Service Market Size Market Share by Players
3.1.1 Global Biologics Contract Manufacturing Service Revenue by Players (2020-2022)
3.1.2 Global Biologics Contract Manufacturing Service Revenue Market Share by Players (2020-2022)
3.2 Global Biologics Contract Manufacturing Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biologics Contract Manufacturing Service by Regions
4.1 Biologics Contract Manufacturing Service Market Size by Regions (2019-2022)
4.2 Americas Biologics Contract Manufacturing Service Market Size Growth (2019-2022)
4.3 APAC Biologics Contract Manufacturing Service Market Size Growth (2019-2022)
4.4 Europe Biologics Contract Manufacturing Service Market Size Growth (2019-2022)
4.5 Middle East & Africa Biologics Contract Manufacturing Service Market Size Growth (2019-2022)
5 Americas
5.1 Americas Biologics Contract Manufacturing Service Market Size by Country (2019-2022)
5.2 Americas Biologics Contract Manufacturing Service Market Size by Type (2019-2022)
5.3 Americas Biologics Contract Manufacturing Service Market Size by Application (2019-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics Contract Manufacturing Service Market Size by Region (2019-2022)
6.2 APAC Biologics Contract Manufacturing Service Market Size by Type (2019-2022)
6.3 APAC Biologics Contract Manufacturing Service Market Size by Application (2019-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biologics Contract Manufacturing Service by Country (2019-2022)
7.2 Europe Biologics Contract Manufacturing Service Market Size by Type (2019-2022)
7.3 Europe Biologics Contract Manufacturing Service Market Size by Application (2019-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biologics Contract Manufacturing Service by Region (2019-2022)
8.2 Middle East & Africa Biologics Contract Manufacturing Service Market Size by Type (2019-2022)
8.3 Middle East & Africa Biologics Contract Manufacturing Service Market Size by Application (2019-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biologics Contract Manufacturing Service Market Forecast
10.1 Global Biologics Contract Manufacturing Service Forecast by Regions (2023-2030)
10.1.1 Global Biologics Contract Manufacturing Service Forecast by Regions (2023-2030)
10.1.2 Americas Biologics Contract Manufacturing Service Forecast
10.1.3 APAC Biologics Contract Manufacturing Service Forecast
10.1.4 Europe Biologics Contract Manufacturing Service Forecast
10.1.5 Middle East & Africa Biologics Contract Manufacturing Service Forecast
10.2 Americas Biologics Contract Manufacturing Service Forecast by Country (2023-2030)
10.2.1 United States Biologics Contract Manufacturing Service Market Forecast
10.2.2 Canada Biologics Contract Manufacturing Service Market Forecast
10.2.3 Mexico Biologics Contract Manufacturing Service Market Forecast
10.2.4 Brazil Biologics Contract Manufacturing Service Market Forecast
10.3 APAC Biologics Contract Manufacturing Service Forecast by Region (2023-2030)
10.3.1 China Biologics Contract Manufacturing Service Market Forecast
10.3.2 Japan Biologics Contract Manufacturing Service Market Forecast
10.3.3 Korea Biologics Contract Manufacturing Service Market Forecast
10.3.4 Southeast Asia Biologics Contract Manufacturing Service Market Forecast
10.3.5 India Biologics Contract Manufacturing Service Market Forecast
10.3.6 Australia Biologics Contract Manufacturing Service Market Forecast
10.4 Europe Biologics Contract Manufacturing Service Forecast by Country (2023-2030)
10.4.1 Germany Biologics Contract Manufacturing Service Market Forecast
10.4.2 France Biologics Contract Manufacturing Service Market Forecast
10.4.3 UK Biologics Contract Manufacturing Service Market Forecast
10.4.4 Italy Biologics Contract Manufacturing Service Market Forecast
10.4.5 Russia Biologics Contract Manufacturing Service Market Forecast
10.5 Middle East & Africa Biologics Contract Manufacturing Service Forecast by Region (2023-2030)
10.5.1 Egypt Biologics Contract Manufacturing Service Market Forecast
10.5.2 South Africa Biologics Contract Manufacturing Service Market Forecast
10.5.3 Israel Biologics Contract Manufacturing Service Market Forecast
10.5.4 Turkey Biologics Contract Manufacturing Service Market Forecast
10.5.5 GCC Countries Biologics Contract Manufacturing Service Market Forecast
10.6 Global Biologics Contract Manufacturing Service Forecast by Type (2023-2030)
10.7 Global Biologics Contract Manufacturing Service Forecast by Application (2023-2030)
11 Key Players Analysis
11.1 Lonza Group
11.1.1 Lonza Group Company Information
11.1.2 Lonza Group Biologics Contract Manufacturing Service Product Offered
11.1.3 Lonza Group Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Lonza Group Main Business Overview
11.1.5 Lonza Group Latest Developments
11.2 Samsung Biologics
11.2.1 Samsung Biologics Company Information
11.2.2 Samsung Biologics Biologics Contract Manufacturing Service Product Offered
11.2.3 Samsung Biologics Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Samsung Biologics Main Business Overview
11.2.5 Samsung Biologics Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Biologics Contract Manufacturing Service Product Offered
11.3.3 Thermo Fisher Scientific Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Cambrex Corporation
11.4.1 Cambrex Corporation Company Information
11.4.2 Cambrex Corporation Biologics Contract Manufacturing Service Product Offered
11.4.3 Cambrex Corporation Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Cambrex Corporation Main Business Overview
11.4.5 Cambrex Corporation Latest Developments
11.5 Siegfried Holding AG
11.5.1 Siegfried Holding AG Company Information
11.5.2 Siegfried Holding AG Biologics Contract Manufacturing Service Product Offered
11.5.3 Siegfried Holding AG Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Siegfried Holding AG Main Business Overview
11.5.5 Siegfried Holding AG Latest Developments
11.6 Fujifilm Holding Corporation
11.6.1 Fujifilm Holding Corporation Company Information
11.6.2 Fujifilm Holding Corporation Biologics Contract Manufacturing Service Product Offered
11.6.3 Fujifilm Holding Corporation Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Fujifilm Holding Corporation Main Business Overview
11.6.5 Fujifilm Holding Corporation Latest Developments
11.7 AbbVie, Inc.
11.7.1 AbbVie, Inc. Company Information
11.7.2 AbbVie, Inc. Biologics Contract Manufacturing Service Product Offered
11.7.3 AbbVie, Inc. Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 AbbVie, Inc. Main Business Overview
11.7.5 AbbVie, Inc. Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Biologics Contract Manufacturing Service Product Offered
11.8.3 Boehringer Ingelheim Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Recipharm Pharmaceuticals
11.9.1 Recipharm Pharmaceuticals Company Information
11.9.2 Recipharm Pharmaceuticals Biologics Contract Manufacturing Service Product Offered
11.9.3 Recipharm Pharmaceuticals Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Recipharm Pharmaceuticals Main Business Overview
11.9.5 Recipharm Pharmaceuticals Latest Developments
11.10 WuXi Biologics
11.10.1 WuXi Biologics Company Information
11.10.2 WuXi Biologics Biologics Contract Manufacturing Service Product Offered
11.10.3 WuXi Biologics Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 WuXi Biologics Main Business Overview
11.10.5 WuXi Biologics Latest Developments
11.11 Catalent, Inc.
11.11.1 Catalent, Inc. Company Information
11.11.2 Catalent, Inc. Biologics Contract Manufacturing Service Product Offered
11.11.3 Catalent, Inc. Biologics Contract Manufacturing Service Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Catalent, Inc. Main Business Overview
11.11.5 Catalent, Inc. Latest Developments
12 Research Findings and Conclusion
no record found